Cubist Systematic Strategies’s Terns Pharmaceuticals TERN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-28,327
| Closed | -$78.2K | – | 2303 |
|
|
2025
Q1 | $78.2K | Buy |
28,327
+16,363
| +137% | +$45.2K | ﹤0.01% | 1279 |
|
|
2024
Q4 | $66.3K | Sell |
11,964
-174,614
| -94% | -$967K | ﹤0.01% | 1307 |
|
|
2024
Q3 | $1.56M | Buy |
+186,578
| New | +$1.56M | 0.01% | 695 |
|
|
2024
Q2 | – | Sell |
-327
| Closed | -$2.15K | – | 2551 |
|
|
2024
Q1 | $2.15K | Buy |
+327
| New | +$2.15K | ﹤0.01% | 2096 |
|
|
2023
Q4 | – | Sell |
-135,015
| Closed | -$679K | – | 2650 |
|
|
2023
Q3 | $679K | Buy |
+135,015
| New | +$679K | 0.01% | 1181 |
|
|
2023
Q2 | – | Sell |
-20,356
| Closed | -$241K | – | 3000 |
|
|
2023
Q1 | $241K | Buy |
20,356
+15,491
| +318% | +$183K | ﹤0.01% | 2134 |
|
|
2022
Q4 | $49.5K | Buy |
+4,865
| New | +$49.5K | ﹤0.01% | 2947 |
|
|
2022
Q3 | – | Sell |
-2,428
| Closed | -$6K | – | 3886 |
|
|
2022
Q2 | $6K | Buy |
2,428
+1,228
| +102% | +$3.04K | ﹤0.01% | 3749 |
|
|
2022
Q1 | $4K | Buy |
+1,200
| New | +$4K | ﹤0.01% | 3486 |
|